28 related articles for article (PubMed ID: 7526655)
1. Activation of CD47 receptors causes histamine secretion from mast cells.
Sick E; Niederhoffer N; Takeda K; Landry Y; Gies JP
Cell Mol Life Sci; 2009 Apr; 66(7):1271-82. PubMed ID: 19205621
[TBL] [Abstract][Full Text] [Related]
2. Role of G-proteins in peptidergic activation of both human and rat cutaneous mast cells.
Emadi-Khiav B; Mousli M; Landry Y
Inflamm Res; 1995 Apr; 44 Suppl 1():S26-7. PubMed ID: 8520984
[No Abstract] [Full Text] [Related]
3. Peptidergic pathway in human skin and rat peritoneal mast cell activation.
Mousli M; Hugli TE; Landry Y; Bronner C
Immunopharmacology; 1994; 27(1):1-11. PubMed ID: 7515863
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of substance P analogs on the activation of GTP-binding regulatory proteins by receptors.
Mukai H; Higashijima T
Regul Pept; 1993 Jul; 46(1-2):338-9. PubMed ID: 7692530
[No Abstract] [Full Text] [Related]
5. Role of positive charges of neuropeptide Y fragments in mast cell activation.
Mousli M; Landry Y
Agents Actions; 1994 Jun; 41 Spec No():C41-2. PubMed ID: 7526655
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y and truncated neuropeptide Y analogs evoke histamine release from rat peritoneal mast cells. A direct effect on G proteins?
Grundemar L; Krstenansky JL; Håkanson R
Eur J Pharmacol; 1994 Jun; 258(1-2):163-6. PubMed ID: 7523149
[TBL] [Abstract][Full Text] [Related]
7. Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli.
Emadi-Khiav B; Mousli M; Bronner C; Landry Y
Eur J Pharmacol; 1995 Jan; 272(1):97-102. PubMed ID: 7536161
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements for neuropeptide Y in mast cell and G protein activation.
Mousli M; Trifilieff A; Pelton JT; Gies JP; Landry Y
Eur J Pharmacol; 1995 Mar; 289(1):125-33. PubMed ID: 7540143
[TBL] [Abstract][Full Text] [Related]
9. A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin.
Bueb JL; Mousli M; Landry Y; Bronner C
Agents Actions; 1990 Apr; 30(1-2):98-101. PubMed ID: 1695472
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
Grundemar L; Håkanson R
Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?
Wahlestedt C; Reis DJ
Annu Rev Pharmacol Toxicol; 1993; 33():309-52. PubMed ID: 8494343
[No Abstract] [Full Text] [Related]
12. The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway.
Fischer T; Bronner C; Landry Y; Mousli M
Biochim Biophys Acta; 1993 Apr; 1176(3):305-12. PubMed ID: 8471631
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.
Tatemoto K; Carlquist M; Mutt V
Nature; 1982 Apr; 296(5858):659-60. PubMed ID: 6896083
[No Abstract] [Full Text] [Related]
14. Activation of rat peritoneal mast cells by substance P and mastoparan.
Mousli M; Bronner C; Bueb JL; Tschirhart E; Gies JP; Landry Y
J Pharmacol Exp Ther; 1989 Jul; 250(1):329-35. PubMed ID: 2473189
[TBL] [Abstract][Full Text] [Related]
15. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.
Mousli M; Bueb JL; Bronner C; Rouot B; Landry Y
Trends Pharmacol Sci; 1990 Sep; 11(9):358-62. PubMed ID: 2122563
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
